New insights of acylation stimulating protein in modulating the pathological progression of metabolic syndromes
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Xi Lian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia Surgery, the First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China. Hauptthemen laut MEDLINE: Metabolic Syndrome, Obesity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 86 Literaturangaben.
Abstract (Originalsprache)
Obesity is associated with insulin resistance, hypertension, and coronary artery diseases which are grouped as metabolic syndrome. Rather than being a storage for energy, the adipocytes could synthesis and secret diverse hormones and molecules, named as adipokines. Under obese status, the adipocytes are dysfunctional with excessively producing the inflammatory related cytokines, such as interleukin 1 (IL-1), IL-6, and tumor necrosis factor α (TNF-α). Concerning on the vital role of adipokines, it is proposed that one of the critical pathological factors of obesity is the dysfunctional adipocytic pathways. Among these adipokines, acylation stimulating protein, as an adipokine synthesized by adipocytes during the process of cell differentiation, is shown to activate the metabolism of triglyceride (TG) by regulating the catabolism of glucose and free fatty acid (FFA). Recent attention has paid to explore the underlying mechanism whereby acylation stimulating protein influences the biological function of adipocyte and the pathological development of obesity. In the present review, we summarized the progression of acylation stimulating protein in modulating the physiological and hormonal catabolism which affects fat distribution. Furthermore, the potential mechanisms which acylation stimulating protein regulates the metabolism of adipose tissue and the process of metabolic syndrome were also summarized.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesia Surgery, the First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.
- Department of Cardiology, the Xiamen Cardiovascular Hospital of Xiamen University, Xiamen, Fujian, China; School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Department of Cardiology, the Xiamen Cardiovascular Hospital of Xiamen University, Xiamen, Fujian, China. Electronic address: kanghuiyuanheart@163.com.
Zitieren
APA
Lian, X., Cheng, Y., & Kang, H. (2024). New insights of acylation stimulating protein in modulating the pathological progression of metabolic syndromes. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112018
Vancouver
Lian X, Cheng Y, Kang H. New insights of acylation stimulating protein in modulating the pathological progression of metabolic syndromes. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112018
BibTeX
@article{Lian2024,
author = {Lian, Xi and Cheng, Ye and Kang, Huiyuan},
title = {New insights of acylation stimulating protein in modulating the pathological progression of metabolic syndromes},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112018}
}
EUVIMED